2 min read
Biopharmaceutical companies worldwide are developing better and most cost-effective medicines at an unprecedented rate. With billions of dollars being invested in research and development, and increased costs for maintaining regulatory compliance,...
Read More
2 min read
Our previous blog discussed the emerging trends for the companion diagnostics (CDx) regulations in China. There have been several developments since...
1 min read
WHAT DOES THIS MEAN? Monkeypox virus is a zoonotic infection, caused by Orthopoxvirus genus of the Poxviridae family like variola virus (the...
4 min read
Veranex has successfully designed and implemented a “5D Framework” to support its Risk Based Monitoring service delivery model. The 5 components are:...
1 min read
Veranex has successfully designed and implemented a “5D Framework” to support its RBM service delivery model, in order to create a better...
2 min read
The many articles discussing the difference between drug and device trials are often coming from a regulatory perspective on how device trials are...
1 min read
Veranex is pleased to have hosted a key meeting with a Generics & Biosimilars Sponsor at the Bangalore, India office on May 31st, 2022. This forum...
2 min read
First-in-Human studies are a discovery point, which can decide the fate of a compound as well as lay the groundwork for subsequent phases of a...
2 min read
It goes without saying that the pandemic has disrupted all aspects of our lives especially the healthcare system, including the diagnostic industry....
